Activity of cediranib, a highly potent and selective VEGF signaling inhibitor, in alveolar soft part sarcoma

Publisher Website

20 May 2009

journal article
sarcoma
Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology

Vol. 27 (15_suppl), 10523
https://doi.org/10.1200/jco.2009.27.15_suppl.10523

Abstract

10523 Background: Alveolar soft part sarcoma (ASPS) is a rare entity making up [Table: see text]

Keywords

Cited by 25 articles